UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FZD7 has a critical role in cell proliferation in triple negative breast cancer

Oncogene, 2011-10, Vol.30 (43), p.4437-4446

2011

Volltextzugriff (PDF)

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1063-1072

2012

Volltextzugriff (PDF)

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study

Leukemia, 2013-12, Vol.27 (12), p.2351-2356

2013

Volltextzugriff (PDF)

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Journal of clinical oncology, 2000-10, Vol.18 (20), p.3558-3585

2000

Volltextzugriff (PDF)

Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer

The pharmacogenomics journal, 2007-10, Vol.7 (5), p.362-365

2007

Volltextzugriff (PDF)

Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies

Leukemia, 2013-05, Vol.27 (5), p.1139-1145

2013

Volltextzugriff (PDF)

Late Lung and Thyroid Toxicities From Total Marrow and Lymphoid Irradiation for Patients Undergoing Hematopoietic Stem Cell Transplantation

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S558-S558

2013

Volltextzugriff (PDF)

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer

Breast cancer research and treatment, 2012-02, Vol.131 (3), p.899-906

2012

Volltextzugriff (PDF)

Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors

Annals of oncology, 2012-04, Vol.23 (4), p.1023-1029

2012

Volltextzugriff (PDF)

Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells

Cell, 2009-08, Vol.138 (3), p.592-603

2009

Volltextzugriff (PDF)

Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome

Annals of oncology, 2008-11, Vol.19 (11), p.1853-1859

2008

Volltextzugriff (PDF)

Total Marrow Irradiation (TMI) with Helical Tomotherapy and Peripheral Blood Progenitor Cell Rescue (PBPC) Following high-Dose Melphalan (Mel) and PBPC as Part of Tandem Autologous Transplant (TAT) for Patients with Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e143-e143

2015

Volltextzugriff (PDF)

Abstract P6-21-08: Synergistic anti-cancer activity of cyclin-dependent kinase 4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing triple negative breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-21-08

2019

Volltextzugriff (PDF)

Abstract P3-06-09: BRCA mutations and not type 1 tandem duplicator phenotypes are associated with pathological complete response in patients with triple negative breast cancer undergoing neoadjuvant carboplatin/nab-paclitaxel

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-06-09

2019

Volltextzugriff (PDF)

Phase I Dose Escalation Trials of Total Marrow Irradiation (TMI) using Helical TomoTherapy (HT) with Concurrent Full-intensity Chemotherapy in Patients with Advanced Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S20-S21

2011

Volltextzugriff (PDF)

Combination Of A Natural Compound (Baicalein) And Paclitaxel Results In Synergistic Apoptosis In Mouse Breast Cancer Cells

The Journal of surgical research, 2011, Vol.165 (2), p.218-219

2011

Volltextzugriff (PDF)

Phase I Study of Bortezomib, Fludarabine, and Melphalan, with or without Total Marrow Irradiation as Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Relapsed/Refractory Multiple Myeloma

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S107-S108

2023

Volltextzugriff (PDF)

Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation

Annals of oncology, 2009-12, Vol.20 (12), p.2000-2006

2009

Volltextzugriff (PDF)

Dendritic Cell Infiltration in Lymph Node Positive Breast Carcinomas

The breast journal, 2009-03, Vol.15 (2), p.218-220

2009

Volltextzugriff (PDF)

Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial: Leo AD, Jerusalem G, Petruzelka L, et al (Hosp of Prato, Italy; Centre Hospitalier Universitaire Sart Tilman and Liège Univ, Belgium; First Faculty of Medicine of Charles Univ, Prague, Czech Republic; et al) J Natl Cancer Inst 106:1-7, 2014

Breast diseases, 2014, Vol.25 (4), p.349-351

Somlo, G.

2014

Volltextzugriff (PDF)

Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial

Breast diseases, 2014, Vol.25 (4), p.349-351

Somlo, G.

2014

Volltextzugriff (PDF)

Identification of Conserved Gene Expression Programs in Epithelial Cancer Stem Cells

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S544-S545

2009

Volltextzugriff (PDF)

Thalidomide as Salvage Therapy for Chronic Graft-Versus-Host Disease

Blood, 1995-11, Vol.86 (9), p.3604-3609

1995

Volltextzugriff (PDF)

Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma

Bone marrow transplantation (Basingstoke), 2006-05, Vol.37 (9), p.825-829

2006

Volltextzugriff (PDF)

PO-1171 Ten-year follow-up of tandem autologous transplantation with total marrow irradiation for myeloma

Radiotherapy and oncology, 2022-05, Vol.170, p.S992-S993

2022

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(328)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(186)
Science & Technology
(180)
Life Sciences & Biomedicine
(170)
Female
(127)
Biological And Medical Sciences
(110)
Adult
(101)
Medical Sciences
(101)
Middle Aged
(100)
Male
(84)
Oncology
(79)
Aged
(56)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(53)
Pharmacology. Drug Treatments
(46)
Antineoplastic Agents
(42)
Chemotherapy
(38)
Treatment Outcome
(37)
Polycystic Kidney, Autosomal Dominant - Genetics
(33)
Genetics & Heredity
(32)
Animals
(31)
Kidneys
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FZD7 has a critical role in cell proliferation in triple negative breast cancer

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer

Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies

Late Lung and Thyroid Toxicities From Total Marrow and Lymphoid Irradiation for Patients Undergoing Hematopoietic Stem Cell Transplantation

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer

Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors

Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells

Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome

Total Marrow Irradiation (TMI) with Helical Tomotherapy and Peripheral Blood Progenitor Cell Rescue (PBPC) Following high-Dose Melphalan (Mel) and PBPC as Part of Tandem Autologous Transplant (TAT) for Patients with Multiple Myeloma

Abstract P6-21-08: Synergistic anti-cancer activity of cyclin-dependent kinase 4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing triple negative breast cancer

Abstract P3-06-09: BRCA mutations and not type 1 tandem duplicator phenotypes are associated with pathological complete response in patients with triple negative breast cancer undergoing neoadjuvant carboplatin/nab-paclitaxel

Phase I Dose Escalation Trials of Total Marrow Irradiation (TMI) using Helical TomoTherapy (HT) with Concurrent Full-intensity Chemotherapy in Patients with Advanced Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)

Combination Of A Natural Compound (Baicalein) And Paclitaxel Results In Synergistic Apoptosis In Mouse Breast Cancer Cells

Phase I Study of Bortezomib, Fludarabine, and Melphalan, with or without Total Marrow Irradiation as Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Relapsed/Refractory Multiple Myeloma

Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation

Dendritic Cell Infiltration in Lymph Node Positive Breast Carcinomas

Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial

Identification of Conserved Gene Expression Programs in Epithelial Cancer Stem Cells

Thalidomide as Salvage Therapy for Chronic Graft-Versus-Host Disease

Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma

PO-1171 Ten-year follow-up of tandem autologous transplantation with total marrow irradiation for myeloma

Suchergebnisse filtern